Cubist Pharmaceuticals Announces the Adoption of Notice and Access Rule for Its 2008 Annual Meeting of Stockholders.2008 Annual Meeting of Stockholders will be Held on Wednesday, June 11(th), 2008 at 55 Hayden Avenue, Lexington, MA LEXINGTON, Mass. -- Cubist Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CBST CBST Center for Biophotonics Science and Technology CBST Congregation Beth Simcha Torah (NYC) CBST Complete Binary Search Tree ) today announced that it has elected to adopt the notice and access or "e-proxy" rules recently adopted by the Securities and Exchange Commission for its 2008 Annual Meeting of Stockholders. These rules allow Cubist to provide stockholders with access to proxy materials Proxy Materials Documents regulated by the Securities & Exchange Commission in which a public company outlines its methods and procedures. These documents are used to inform shareholders and solicit votes for corporate decisions, such as the election of directors and other for the Annual Meeting via the Internet. Taking advantage of these new rules will allow Cubist to lower the cost of printing and mailing proxy materials to its stockholders and reduce the environmental impact of printing and mailing these materials. Stockholders have been sent a notice by mail that details how to access the proxy materials and vote their shares via the Internet. The notice also provides stockholders with instructions on how to request hard copies of the proxy materials at no charge. Cubist's Annual Meeting of Shareholders will be held on Wednesday, June 11, 2008 at 8:30 A.M. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT at 55 Hayden Avenue, Lexington, MA. About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN[R] (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. The Cubist product pipeline includes DX-88, a recombinant human protein in Phase II clinical trials for the prevention of blood loss during cardiothoracic surgery, and pre-clinical programs that address unmet medical needs in Gram-positive infections, Gram-negative infections, CDAD CDAD Clostridium Difficile-Associated Diarrhea CDAD Component Data Administrator (Clostridium clostridium Any of the rod-shaped, usually gram-positive bacteria (see gram stain) that make up the genus Clostridium. They are found in soil, water, and the intestinal tracts of humans and other animals. Some species grow only in the complete absence of oxygen. difficile-associated diarrhea), and HCV HCV abbr. hepatitis C virus HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus. (Hepatitis C infections). Cubist is headquartered in Lexington, MA. Additional information can be found at Cubist's web site at www.cubist.com. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion